Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT02957526 · ClinicalTrials.gov registry record · NA

Web-Base App To Improve Aromatase Inhibitor Adherence

A NA study of Breast Neoplasm Female, sponsored by University of Tennessee.

Completed
Registry status
NA
Development phase
44
Enrollment target
2
Study locations

NCT02957526 is a NA study of Breast Neoplasm Female that has completed, run by University of Tennessee. The registered enrollment target is 44 participants, below the 175-participant average among 8 other Breast Neoplasm Female trials with a reported enrollment target (75% lower). The trial reports 2 study locations across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT02957526, a NA study of Breast Neoplasm Female, has completed, sponsored by University of Tennessee.

COMPLETED
Registry status
NA
Development phase
44 participants
Enrollment target
2
Study locations

Study Summary

The purpose of this study will be to test the use of a web-based mobile application (app) initiated at the time of the initial prescription to an aromatase inhibitor to improve communication and management of treatment-related adverse symptoms among patients with hormone-receptor positive breast cancer.

Conditions Studied

Breast Neoplasm Female

Interventions

  • BEHAVIORAL Prompts to report symptoms via study app
  • BEHAVIORAL Clinical Alerts

Study Locations (2)

Tennessee

  • West Cancer Center, MIDTOWN, 1588 Union Ave. - Memphis
  • West Cancer Center, EAST MEMPHIS, 7945 Wolf River Blvd - Memphis

Trial Details

FieldValue
Enrollment Target 44 participants
Start Date 2015-12
Est. Completion 2016-07
Phase NA

Sponsor

University of Tennessee

96 total trials

Interested in This Trial?

Full Details on ClinicalTrials.gov ↗

What the Registry Record Tells You About NCT02957526

The ClinicalTrials.gov registry entry for NCT02957526 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 44 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 175-participant average among 8 other Breast Neoplasm Female trials with a reported enrollment target (75% lower). The listed sponsor is University of Tennessee, which has 96 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Breast Neoplasm Female appearing as the primary indexed condition, and to 2 interventions - of which Prompts to report symptoms via study app is the first listed.

NCT02957526 reports 2 study locations spanning 1 distinct geographic area - top geographies include Tennessee.

Frequently Asked Questions

What is clinical trial NCT02957526 about?

NCT02957526 is a clinical study titled "Web-Base App To Improve Aromatase Inhibitor Adherence". The purpose of this study will be to test the use of a web-based mobile application (app) initiated at the time of the initial prescription to an aromatase inhibitor to improve communication and management of treatment-related adverse symptoms among patients with hormone-receptor positive breast can...

What is the current status of trial NCT02957526?

This trial is currently completed. It is a NA study. The enrollment target is 44 participants. The study started on 2015-12. Estimated completion is 2016-07.

What conditions does trial NCT02957526 study?

This clinical trial studies the following conditions: Breast Neoplasm Female.

What interventions are being tested in trial NCT02957526?

The interventions under investigation include: Prompts to report symptoms via study app (BEHAVIORAL), Clinical Alerts (BEHAVIORAL).

Who is sponsoring clinical trial NCT02957526?

This trial is sponsored by University of Tennessee, which has 96 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT02957526 being conducted?

This trial has 2 study locations across Tennessee. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Learn More About Clinical Trials

Similar trials for Breast Neoplasm Female

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Explore more on PlainTrial

Breast Neoplasm Female

All registered trials for this condition

Tennessee

All trials with a study site in Tennessee

Recruiting now

Find trials open to new participants near you

Rankings

Top sponsors, conditions, and phases

Read our methodology - how this data is sourced, computed, and verified.

Related

Browse all → | Rankings →
Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.